Alliancebernstein L.P. Biocryst Pharmaceuticals Inc Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 275,790 shares of BCRX stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

275,790

Previous 275,790 -0.0%

Holding current value

$2.09 Million

Previous $1.7 Million 23.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.13 - $6.79 $163,424 - $268,680	39,570 Added 16.75%	275,790 $1.7 Million
Q4 2023 Feb 14, 2024	SELL	$4.98 - $6.77 $4.24 Million - $5.76 Million	-850,456 Reduced 78.26%	236,220 $1.41 Million
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $5.71 Million - $6.74 Million	850,456 Added 360.03%	1,086,676 $7.69 Million
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $5,250 - $7,100	500 Added 0.21%	236,220 $2.71 Million
Q2 2022 Aug 15, 2022	BUY	$7.89 - $17.88 $261,159 - $591,828	33,100 Added 16.34%	235,720 $2.49 Million
Q1 2022 May 13, 2022	SELL	$11.56 - $19.76 $361,828 - $618,488	-31,300 Reduced 13.38%	202,620 $3.3 Million
Q3 2021 Nov 10, 2021	SELL	$14.21 - $17.65 $48,314 - $60,009	-3,400 Reduced 1.43%	233,920 $3.36 Million
Q2 2021 Jul 30, 2021	BUY	$9.5 - $17.24 $323,950 - $587,884	34,100 Added 16.78%	237,320 $3.75 Million
Q1 2021 May 06, 2021	BUY	$7.37 - $13.61 $179,828 - $332,084	24,400 Added 13.65%	203,220 $2.07 Million
Q3 2020 Nov 12, 2020	SELL	$3.43 - $5.53 $33,957 - $54,747	-9,900 Reduced 5.25%	178,820 $614,000
Q2 2020 Aug 13, 2020	SELL	$1.9 - $5.61 $99,940 - $295,086	-52,600 Reduced 21.8%	188,720 $899,000
Q1 2020 May 14, 2020	BUY	$1.6 - $4.11 $140,160 - $360,036	87,600 Added 56.99%	241,320 $483,000
Q3 2019 Nov 14, 2019	BUY	$2.5 - $3.73 $31,750 - $47,371	12,700 Added 9.01%	153,720 $440,000
Q2 2019 Aug 14, 2019	BUY	$2.91 - $9.15 $71,877 - $226,005	24,700 Added 21.23%	141,020 $534,000
Q1 2018 May 14, 2018	BUY	$4.35 - $5.82 $73,515 - $98,358	16,900 Added 17.0%	116,320 $555,000
Q3 2017 Nov 13, 2017	BUY	$4.1 - $5.97 $407,621 - $593,537	99,420	99,420 $521,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Biocryst Pharmaceuticals Inc Transaction History